Joyce Meghan V. sold $14K of GH
Joyce Meghan V. sold 106 shares of Guardant Health, Inc. (GH) at $129.31 on 2026-06-03 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
This disclosure updates insider activity records but does not provide new operational, financial, or regulatory information about Guardant Health.
Market read
Traders may monitor insider activity for sentiment, but 10b5-1 pre-arrangement generally lowers the probability of a meaningful fundamental read-through.
What to watch
The filing does not indicate whether other insiders or institutions changed positions around the same time; without that context, the signal is limited.
Background
SEC Form 4 insider transaction: director Joyce Meghan V. sold 106 shares of Guardant Health on June 3 at ~$129.31/share; holdings after sale were 11,183 shares.
Ticker impact
Guardant Health director Joyce Meghan V. filed an open-market sale of 106 shares under a pre-arranged 10b5-1 plan on June 3.
Small, short-lived negative-to-neutral drift possible; unlikely to change valuation absent other catalysts.
The transaction is an open-market sale and explicitly tied to a pre-arranged 10b5-1 plan, which typically reduces interpretive weight versus discretionary selling.
Market effects
Minimal; this is company-specific insider disclosure with no sector-wide catalyst stated.
None indicated.
None indicated.
Counterpoint
Because the sale is under a pre-arranged 10b5-1 plan, it may reflect routine liquidity rather than bearish expectations, so price impact may be negligible.
Key entities
- issuerGuardant Health, Inc.
Subject of the Form 4 insider sale disclosure.
- insiderJoyce Meghan V.
Director who executed the open-market sale under a 10b5-1 plan.
